
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 349 - OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
##### Subpart C - Labeling
###### ยง 349.75 Labeling of ophthalmic vasoconstrictor drug products.
####### Warnings.

(c)In addition to the warnings in ยง 349.50, the labeling of the product contains the following warnings under the heading "Warnings" for products containing any ingredient identified in ยง 349.18:

(1) "If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor."

(2) "Ask a doctor before use if you have [in bold type] narrow angle glaucoma."

(3) "Overuse of this product may produce increased redness of the eye."

(4) "If solution changes color or becomes cloudy, do not use."

(5) "When using this product [in bold type] pupils may become enlarged temporarily."
